We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
Directeur du programme de formation complémentaire en médecine d’urgence, Université Laval, Québec (Qué.)
*
Directeur du programme de formation complémentaire en médecine d’urgence, Faculté de médecine, Université Laval, Québec QC G1K 7P4; Claude.topping@mfa.ulaval.ca
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
1.Ziegler, MG, Lew, P, Singer, BC.The accuracy of drug information from pharmaceutical sales representatives. JAMA1995; 273:1296–8.CrossRefGoogle ScholarPubMed
2
2.Wazana, A.Physicians and the pharmaceutical industry: Is a gift ever just a gift?JAMA2000;283:373–80.CrossRefGoogle ScholarPubMed
3
3.Orlowski, JP, Wateska, L.The effects of pharmaceutical firm enticements on physician prescribing patterns. There’s no such thing as a free lunch. Chest1992;102(1):270–3.CrossRefGoogle ScholarPubMed
4
4.Chren, MM, Landefeld, CS.Physicians’ behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA1994;271(9):684–9.CrossRefGoogle ScholarPubMed
5
5.Steinman, MA, Shlipak, MG, McPhee, SJ.Of principles and pens: attitudes and practices of medecine housestaff toward pharmaceutical industry promotions. Am J Med2001;110(7):551–7.CrossRefGoogle Scholar